About the Author
My name is Mark Senak. I’m a lawyer and I work at the international communications firm FleishmanHillard in New York. For the past several years, I have been consulting with pharmaceutical and biologic companies that are engaged in the process of bringing new drugs to market. I have also worked extensively with an array of medical societies and patient organizations providing strategic communications counsel and media training.
Daily Archives: January 22, 2008
Approval Outlook for 2008
As I’ve noted in recent posts, the situation in 2007 was pretty rough for new drug approvals. We saw an increase in approvable letters, and a decrease in the percentage of approval letters. Will it get better in 2008? I … Continue reading
Posted in FDA Policy
Comments Off on Approval Outlook for 2008